Insider · CIK 0001668116
Hila Karah
Files at DRIO (DarioHealth Corp.), INDP (Indaptus Therapeutics, Inc.). First filing -, latest -.
In brief
Hila Karah files SEC Form 4 as director at DRIO (DarioHealth Corp.), and also at INDP (Indaptus Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Hila Karah has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | DRIO DarioHealth Corp. | AGrant or award Common Stock | +28,000 | $0.00 | $0 | 58,965 | 16 d ago |
| Sep 11, 2025 | DRIO DarioHealth Corp. | AGrant or award Common Stock | +20,000 | $0.00 | $0 | 30,965 | Sep 15, 2025 |
| Jun 10, 2025 | INDP Indaptus Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +12,500 | $0.00 | $0 | 12,500 | Jun 11, 2025 |
| Apr 10, 2025 | INDP Indaptus Therapeutics, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -500 | $0.39 | $195 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | INDP Indaptus Therapeutics, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -250 | $0.39 | $98 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | INDP Indaptus Therapeutics, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -281 | $0.39 | $110 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | INDP Indaptus Therapeutics, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -250 | $0.39 | $98 | 0 | Apr 11, 2025 |
| Jun 6, 2024 | INDP Indaptus Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +12,500 | $0.00 | $0 | 12,500 | Jun 7, 2024 |
| Mar 6, 2024 | DRIO DarioHealth Corp. | AGrant or award Common Stock | +70,000 | $0.00 | $0 | 219,290 | Mar 8, 2024 |
Questions about Hila Karah
Answered from the filings on this page, as of the latest one.
Is Hila Karah buying or selling?
Hila Karah has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Hila Karah's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Hila Karah has 0.
Where does Hila Karah file Form 4?
Hila Karah has filed Form 4 at DRIO (DarioHealth Corp.); INDP (Indaptus Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.